Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

227 views

Visitors from

US 53%·

AU 33%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Low-Volatility Stocks That Fall Short

By: StockStory

December 28, 2025 at 23:38 PM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

TMO Cover Image

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Luckily for you, StockStory helps you navigate which companies are truly worth holding. Keeping that in mind, here are three low-volatility stocks to avoid and some better opportunities instead.

Thermo Fisher (TMO)

Rolling One-Year Beta: 0.78

With over 14,000 sales personnel and a portfolio spanning more than 2,500 technology manufacturers, Thermo Fisher Scientific (NYSE: TMO) provides scientific equipment, reagents, consumables, software, and laboratory services to pharmaceutical, biotech, academic, and healthcare customers worldwide.

Why Are We Wary of TMO?

Sales were flat over the last two years, indicating it’s failed to expand this cycle
Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
Costs have risen faster than its revenue over the last five years, causing its adjusted operating margin to decline by 9.2 percentage points

At $580.79 per share, Thermo Fisher trades at 24x forward P/E. Read our free research report to see why you should think twice about including TMO in your portfolio.

Encompass Health (EHC)

Rolling One-Year Beta: 0.64

With a network of 161 specialized facilities across 37 states and Puerto Rico, Encompass Health (NYSE: EHC) operates inpatient rehabilitation hospitals that help patients recover from strokes, hip fractures, and other debilitating conditions.

Why Are We Cautious About EHC?

Annual revenue growth of 4.7% over the last five years was below our standards for the healthcare sector
Free cash flow margin shrank by 1.3 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive

Encompass Health’s stock price of $107.50 implies a valuation ratio of 19x forward P/E. To fully understand why you should be careful with EHC, check out our full research report (it’s free for active Edge members).

Stellar Bancorp (STEL)

Rolling One-Year Beta: 0.92

Created through strategic mergers to serve the growing Texas business community, Stellar Bancorp (NYSE: STEL) is a Texas bank holding company that provides commercial banking services primarily to small and medium-sized businesses and professionals.

Why Do We Avoid STEL?

Sales tumbled by 5.8% annually over the last two years, showing market trends are working against its favor during this cycle
Concessions to defend its market share have ramped up over the last two years as its net interest margin decreased by 36 basis points (100 basis points = 1 percentage point)
Earnings per share decreased by more than its revenue over the last two years, showing each sale was less profitable

Stellar Bancorp is trading at $31.18 per share, or 1x forward P/B. If you’re considering STEL for your portfolio, see our FREE research report to learn more.

Stocks We Like More

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	272.68	+1.51 (0.56%)
AAPL	293.32	+5.88 (2.05%)
AMD	455.19	+46.73 (11.44%)
BAC	51.31	-1.44 (-2.73%)
GOOG	397.05	+1.75 (0.44%)
META	609.63	-7.18 (-1.16%)
MSFT	415.12	-5.65 (-1.34%)
NVDA	215.20	+3.70 (1.75%)
ORCL	195.95	+1.36 (0.70%)
TSLA	428.35	+16.56 (4.02%)